News

Significant progress is being made toward diagnosis, evaluation and management of sensori-motor dysfunction, gut microbiota, gut-brain axis, nutrition, eosinophilic esophagitis. Read the most recent news here.

Abstract submission opens on February 1st, 2023

NeuroGASTRO 2023 is not so far away! Abstract submission will open on February 1st, 2023. Be part of our great programme and meet outstanding speakers. Learn more about our latest abstract topics on the meeting website www.neurogastro2023.org. We are looking forward to receiving many submissions!

Little brain big brain Extraordinary meeting 2022

Since its initiation in the late 1980s, Little Brain Big Brain has been dedicated to bring together the most promising and motivated junior scientists and clinicians in the field of functional gut brain disorders (FGBD), neurogastroenterology and motility. This year, LBBB took place in Heiligkreuztal, Germany from the 5th to 9th of September.

Graphic Abstract: Association Between Psychosocial Disorders and Gastroesophageal Reflux Disease

Gastroesophageal reflux disease (GERD) is a common upper gastrointestinal tract disorder. The main cause of GERD is a reflux of stomach and duodenum contents into the esophagus, which results in – among others – acid reflux and heartburn. It is estimated that over 1 billion people worldwide suffer from GERD.

The FunDysGWAS ESNM Project

The aim of this project is to create an European based database to investigate the role of different genetic factors that might be linked to functional dyspepsia (FD) symptoms. At present, the project group has collected samples 196 of FD patients and 190 samples of healthy controls. The project ist looking for new centers in Europe that would like to help and are eager to recruit 50 patients or more diagnosed with functional dyspepsia as described by the Rome IV criteria and if possible 50 healthy controls during the next year.

Read more … The FunDysGWAS ESNM Project

DISCOvERIE: Better diagnose, prevention and treatment for IBS patients

The EU-funded project DISCOvERIE has reached the 50% of its timeline to position Europe as a global leader in comorbid IBS personalised medicine. The main hypothesis is that comorbid IBS represents a distinct clinical entity, arising from distorted brain-gut communication with a unique, specific, but undefined pathophysiological origin, differing from IBS alone.

Two I-NGM Meetings in 2022

What a highlight! In fact two Israeli NeuroGASTRO meetings were held in June/July 2022: The annual meeting of I-NGM took place in Nazareth from June 30 to July 1. Leading national and international experts attended to exchange and discuss latest findings on esophageal diseases and particularly GERD. The semi-annual meeting of the Israel Gastroenterology Association (IGA) took place in Tel Aviv on July 19.

Read more … Two I-NGM Meetings in 2022

IBS Days in Bologna with experts from all over the world

"New insights for a better management of irritable bowel syndrome" was the motto of this years IBS Days in Bologna with experts from all over the world. The 2022 edition of the biennial IBS DAYS congress was held in Bologna on June 20-22 and provided current views and a look to the future on the rapidly advancing field of IBS.

New guideline is out: Functional bowel disorders with diarrhoea

Irritable bowel syndrome with diarrhoea (IBS-D) and functional diarrhoea (FDr) are the two major functional bowel disorders characterized by diarrhoea. UEG and ESNM published the new clinical guideline “Functional bowel disorders with diarrhoea”. Learn more about this clinically helpful tool to provide best-practice based healthcare among a large group of patients.